OBJECTIVE: To compare anthroposophic treatment (eurythmy, rhythmical massage or art therapy; counselling, anthroposophic medication) and conventional treatment for low back pain (LBP) under routine conditions. METHODS: 62 consecutive outpatients from 38 medical practices in Germany, consulting an anthroposophic (A-) or conventional (C-) physician with LBP of >or= 6 weeks duration participated in a prospective non-randomised comparative study. Main outcomes were Hanover Functional Ability Questionnaire (HFAQ), LBP Rating Scale Pain Score (LBPRS), Symptom Score, and SF-36 after 6 and 12 months. RESULTS: At baseline, LBP duration was > 6 months in 85% (29/34) of A-patients and 54% (15/28) of C-patients (p = 0.004). Unadjusted analysis showed significant improvements in both groups of HFAQ, LBPRS, Symptom Score, SF-36 Physical Component Summary, and three SF-36 scales (Physical Function, Pain, Vitality), and improvements in A-patients of three further SF-36 scales (Role Physical, General Health, Mental Health). After adjustment for age, gender, LBP duration, and education, improvements were still significant in both groups for Symptom Score (p = 0.030), SF-36 Physical Component Summary (p = 0.004), and three SF-36-scales (Physical Function, p = 0.025; Role Physical, p = 0.014; Pain, p = 0.003), and in A-patients for SF-36-Vitality (p = 0.032). Compared to C-patients, A-patients had significantly more pronounced improvements of three SF-36 scales (Mental Health: p = 0.045; General Health: p = 0.006; Vitality: p = 0.005); other improvements did not differ significantly between the two groups. CONCLUSION: Compared to conventional therapy, anthroposophic therapy for chronic LBP was associated with at least comparable improvements.
OBJECTIVE: To compare anthroposophic treatment (eurythmy, rhythmical massage or art therapy; counselling, anthroposophic medication) and conventional treatment for low back pain (LBP) under routine conditions. METHODS: 62 consecutive outpatients from 38 medical practices in Germany, consulting an anthroposophic (A-) or conventional (C-) physician with LBP of >or= 6 weeks duration participated in a prospective non-randomised comparative study. Main outcomes were Hanover Functional Ability Questionnaire (HFAQ), LBP Rating Scale Pain Score (LBPRS), Symptom Score, and SF-36 after 6 and 12 months. RESULTS: At baseline, LBP duration was > 6 months in 85% (29/34) of A-patients and 54% (15/28) of C-patients (p = 0.004). Unadjusted analysis showed significant improvements in both groups of HFAQ, LBPRS, Symptom Score, SF-36 Physical Component Summary, and three SF-36 scales (Physical Function, Pain, Vitality), and improvements in A-patients of three further SF-36 scales (Role Physical, General Health, Mental Health). After adjustment for age, gender, LBP duration, and education, improvements were still significant in both groups for Symptom Score (p = 0.030), SF-36 Physical Component Summary (p = 0.004), and three SF-36-scales (Physical Function, p = 0.025; Role Physical, p = 0.014; Pain, p = 0.003), and in A-patients for SF-36-Vitality (p = 0.032). Compared to C-patients, A-patients had significantly more pronounced improvements of three SF-36 scales (Mental Health: p = 0.045; General Health: p = 0.006; Vitality: p = 0.005); other improvements did not differ significantly between the two groups. CONCLUSION: Compared to conventional therapy, anthroposophic therapy for chronic LBP was associated with at least comparable improvements.
Authors: Elke Jeschke; Thomas Ostermann; Manuela Tabali; Horst C Vollmar; Matthias Kröz; Angelina Bockelbrink; Claudia M Witt; Stefan N Willich; Harald Matthes Journal: BMC Geriatr Date: 2010-07-21 Impact factor: 3.921
Authors: Harald J Hamre; Claudia M Witt; Gunver S Kienle; Anja Glockmann; Renatus Ziegler; Stefan N Willich; Helmut Kiene Journal: J Pain Res Date: 2009-06-25 Impact factor: 3.133
Authors: Daniel Pach; Benno Brinkhaus; Stephanie Roll; Karl Wegscheider; Katja Icke; Stefan N Willich; Claudia M Witt Journal: PLoS One Date: 2011-11-08 Impact factor: 3.240
Authors: Harald J Hamre; Anja Glockmann; Wilfried Tröger; Gunver S Kienle; Helmut Kiene Journal: BMC Med Res Methodol Date: 2008-03-19 Impact factor: 4.615
Authors: Harald Johan Hamre; Helmut Kiene; Renatus Ziegler; Wilfried Tröger; Christoph Meinecke; Christof Schnürer; Hendrik Vögler; Anja Glockmann; Gunver Sophia Kienle Journal: Glob Adv Health Med Date: 2014-01
Authors: Harald J Hamre; Claudia M Witt; Anja Glockmann; Renatus Ziegler; Gunver S Kienle; Stefan N Willich; Helmut Kiene Journal: Drug Des Devel Ther Date: 2009-02-06 Impact factor: 4.162
Authors: Harald J Hamre; Claudia M Witt; Anja Glockmann; Renatus Ziegler; Stefan N Willich; Helmut Kiene Journal: BMC Public Health Date: 2007-04-23 Impact factor: 3.295
Authors: Harald J Hamre; Claudia M Witt; Anja Glockmann; Renatus Ziegler; Stefan N Willich; Helmut Kiene Journal: BMC Complement Altern Med Date: 2007-04-23 Impact factor: 3.659
Authors: Arndt Büssing; Thomas Ostermann; Magdalena Majorek; Peter F Matthiessen Journal: BMC Complement Altern Med Date: 2008-03-31 Impact factor: 3.659